U.S. Markets open in 3 hrs 24 mins
  • S&P Futures

    -59.75 (-1.52%)
  • Dow Futures

    -442.00 (-1.41%)
  • Nasdaq Futures

    -200.25 (-1.68%)
  • Russell 2000 Futures

    -24.40 (-1.38%)
  • Crude Oil

    -2.20 (-2.01%)
  • Gold

    +9.00 (+0.50%)
  • Silver

    -0.06 (-0.27%)

    +0.0036 (+0.3466%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • Vix

    +6.86 (+26.28%)

    +0.0060 (+0.4824%)

    -0.6000 (-0.4677%)

    -948.06 (-3.16%)
  • CMC Crypto 200

    -25.71 (-3.83%)
  • FTSE 100

    -201.13 (-2.70%)
  • Nikkei 225

    -508.36 (-1.89%)

Some Analysts Just Cut Their Limoneira Company (NASDAQ:LMNR) Estimates

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The analysts covering Limoneira Company (NASDAQ:LMNR) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic.

Following the downgrade, the current consensus from Limoneira's five analysts is for revenues of US$187m in 2021 which - if met - would reflect a meaningful 14% increase on its sales over the past 12 months. Before the latest update, the analysts were foreseeing US$208m of revenue in 2021. The consensus view seems to have become more pessimistic on Limoneira, noting the measurable cut to revenue estimates in this update.

Check out our latest analysis for Limoneira


There was no particular change to the consensus price target of US$18.60, with Limoneira's latest outlook seemingly not enough to result in a change of valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Limoneira analyst has a price target of US$20.00 per share, while the most pessimistic values it at US$17.00. Still, with such a tight range of estimates, it suggests the analysts have a pretty good idea of what they think the company is worth.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. Next year brings more of the same, according to the analysts, with revenue forecast to grow 14%, in line with its 12% annual growth over the past five years. Compare this with the wider industry, which analyst estimates (in aggregate) suggest will see revenues grow 3.1% next year. So although Limoneira is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that analysts cut their revenue estimates for this year. The analysts also expect revenues to grow faster than the wider market. Overall, given the drastic downgrade to this year's forecasts, we'd be feeling a little more wary of Limoneira going forwards.

Unsatisfied? We have estimates for Limoneira from its five analysts out until 2022, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.